245206
Evaluation of the South Carolina's Screening Colonoscopy On People Everywhere (SCOPE) Program for the Uninsured
Tuesday, November 1, 2011: 5:30 PM
Sudha Xirasagar, MBBS, PhD
,
Dept of Health Services Policy and Management, University of South Carolina, Arnold School of Public Health, Columbia, SC
Thomas G. Hurley, MS
,
Statewide Cancer Prevention and Control Program, University of South Carolina, Columbia, SC
Virginie Daguise, PhD
,
Bureau of Community Health and Chronic Disease Prevention, Division of Cancer, South Carolina Deaprtment of Health and Environmental Control, Columbia, SC
Yi-Jhen Li, MHA
,
Dept of Health Services Policy and Management, University of South Carolina, Arnold School of Public Health, Columbia, SC
Lou-Ann Carter, MS
,
Division of Injury and Violence Prevention, South Carolina Department of Health and Environmental Control, Columbia, SC
Sonya Younger, MPH
,
Bureau of Community Health and Chronic Disease Prevention, Division of Cancer, South Carolina Dept. Of Health and Environmental Control, Columbia, SC
James B. Burch, PhD
,
Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC
James R. Hebert, ScD
,
Cancer Prevention and Control Program, University of South Carolina, Columbia, SC
Background: Screening colonoscopy remains the gold standard public health tool for colorectal cancer prevention. The SCOPESC program was funded by the South Carolina Department of Health and Environmental Control with $1 million to expand screening colonoscopy services to the indigent, consistent with the State Cancer Plan. During Year I, a total of 682 qualifying individuals (income below 200% of federal poverty and no insurance coverage for colonoscopy) were provided the service at 5 provider sites. All providers submitted colonoscopy and pathology report information as a condition of being reimbursed under the program. We present a performance evaluation for Year 1. Objective: To assist SCOPESC in optimizing its cancer prevention potential by providing an assessment of colonoscopy quality indicators relative to national benchmarks. Methods: Deviations from nationally accepted quality benchmarks including polyp and adenoma detection rates, and bowel preparation quality were studied, and quality-associated variables identified for potential quality improvement efforts. Analyses include logistic (including multinomial) regression modeling. Analyses include logistic (including multinomial) regression modeling. Findings: Of 665 persons with data available, 71.1% are female, 70.3% African-American, 56.1% had at least one polyp, and 26.6% at least one adenoma. The sample age, gender, race and geographic distribution relative to polyp and adenoma rates and characteristics will be presented. Conclusions: Findings are discussed against the backdrop of South Carolina's colorectal cancer incidence and mortality profile, and the potential of SCOPE-SC to reduce colorectal cancer disparities will be discussed, Implications for program expansion to reach a larger indigent population will be discussed.
Learning Areas:
Administer health education strategies, interventions and programs
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Learning Objectives: To describe the operational performance measures of a publicly funded screening colonoscopy program implemented under community practice conditions
To describe variations in screening colonoscopy outcomes by patient and provider sub-populations and how such findings can be used to optimize program impacts
Keywords: Disease Prevention, Screening
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am the PI on this project and leading this evaluation research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|